Golnar Rahimzadeh | Medicine | Best Researcher Award

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Postdoctoral Research Fellow, Mass General Brigham, United States

Lova Prasadareddy Kajuluri is a Postdoctoral Research Fellow at the Cardiovascular Research Center, Massachusetts General Hospital (MGH), Charlestown, USA. He is recognized for his significant contributions to cardiovascular research, particularly in understanding vascular calcification and its potential treatments. With a strong background in biotechnology, Kajuluri has advanced in his research career through various prestigious roles in both India and the United States. He holds a Doctorate in Science from the CSIR-Central Drug Research Institute, Lucknow, India, and has received multiple research grants to further his studies in cardiovascular diseases. 🚀

Publication Profile

Education Background

Kajuluri’s educational journey began with a Bachelor of Science in Biotechnology, Biochemistry, and Chemistry from Andhra University in 2007. He continued to pursue a Master of Science in Biotechnology from Andhra University, followed by a Ph.D. in Science from CSIR-Central Drug Research Institute, India. His academic excellence has paved the way for several postdoctoral positions, starting from his research fellowship at Boston University to his current position at Massachusetts General Hospital, where he continues to explore novel therapies in cardiovascular research. 🎓📚

Professional Experience

Kajuluri’s professional career began as a Research Fellow at CSIR-Central Drug Research Institute in India, focusing on Leishmaniasis and actin-related proteins. He transitioned to postdoctoral research at Boston University, where he led studies on vascular smooth muscle contraction and calponin. His current role as a Postdoctoral Research Fellow at MGH involves leading studies on vascular calcification, gene therapy, and identifying therapeutic targets to treat cardiovascular diseases. His extensive research in these areas contributes significantly to the advancement of vascular health. 🔬🧑‍🔬

Awards and Honors

Kajuluri has received numerous prestigious awards throughout his career. Notably, he was awarded the Research Fellowship from the University Grants Commission, New Delhi, India (2011-2016). He has also been a part of several funded research projects, including those supported by the National Heart, Lung, and Blood Institute, USA. His dedication to advancing cardiovascular and infectious disease research has earned him recognition from the scientific community. 🏆🎖️

Research Focus

Kajuluri’s research is focused on understanding the molecular mechanisms underlying vascular calcification, a condition that contributes to cardiovascular diseases. His current studies explore gene therapies to treat vascular calcification in infants, as well as the role of histone deacetylases in vascular health. Additionally, his earlier work in Leishmaniasis has expanded his expertise to parasitology and cellular biology. His work bridges cardiovascular research and therapeutic innovation, offering potential treatments for critical vascular conditions. ❤️🧬

Conclusion

Lova Prasadareddy Kajuluri’s career is a testament to his commitment to advancing science in cardiovascular health and infectious diseases. Through his research, he continues to provide invaluable insights into vascular calcification and gene therapy, offering hope for future treatments in these fields. 🌟🔬

Publication Top Notes

Epigenetic Regulation of Human Vascular Calcification. Genes, 2025, 16, 506. DOI

Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle.  Journal of Cellular and Molecular Medicine, January 28, 2024. PubMed

Treatment of calcific arterial disease via enhancement of autophagy using GSK343.  iScience, October 28, 2023. PubMed

Intracellular localization of MyosinXXI discriminates Leishmania spp and Leptomonas seymouri.  Biochemical and Biophysical Research Communications, May 14, 2022. PubMed

Actin-related protein 4: An unconventional negative regulator of mitochondrial calcium in protozoan parasite Leishmania.  Mitochondrion, Jan 2022. PubMed

Vascular aging, the vascular cytoskeleton and aortic stiffness.  Exploration of Medicine, June 2021. PubMed

The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function.  Current Opinion in Physiology, February 2020. ScienceDirect

A twinfilin-like protein coordinates karyokinesis by influencing mitotic spindle elongation and DNA replication in Leishmania.  Molecular Microbiology, April 2016. PubMed

Oligomerization of coronin: Implication on actin filament length in Leishmania. Cytoskeleton (Hoboken, N.J.), December 2015. PubMed